Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN – Research Report), ImmunoGen (IMGN – Research Report) and Guardant Health (GH – Research Report). Amgen (AMGN) In a report issued on May 22, Jim Kelly from SVB Securities initiated coverage with a Hold rating on Amgen and a price target of $256.00. The company's shares closed last Monday at $249.04, close to its 52-week high of $258.45. According to TipRanks.com, Kelly is ranked #7317 out of 7890 analysts. The word on The Street in general, suggests a Hold analyst consensus rating for Amgen with a $241.23 average price target, a -3.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-immunogen-imgn-and-guardant-health-gh?utm_source=advfn.com&utm_medium=referral
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more ImmunoGen Charts.
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more ImmunoGen Charts.